Financial results - ONCOPLASTICA MED SRL

Financial Summary - Oncoplastica Med Srl
Unique identification code: 35916710
Registration number: J40/5019/2016
Nace: 8622
Sales - Ron
439.725
Net Profit - Ron
337.330
Employee
3
The most important financial indicators for the company Oncoplastica Med Srl - Unique Identification Number 35916710: sales in 2023 was 439.725 euro, registering a net profit of 337.330 euro and having an average number of 3 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Oncoplastica Med Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 96.872 171.988 160.505 327.192 261.116 443.309 347.090 439.725
Total Income - EUR - - 96.872 171.988 160.505 327.320 264.133 443.653 347.561 441.534
Total Expenses - EUR - - 8.484 36.842 58.907 73.961 78.114 100.832 93.377 99.877
Gross Profit/Loss - EUR - - 88.388 135.146 101.598 253.359 186.020 342.821 254.184 341.657
Net Profit/Loss - EUR - - 87.088 133.425 99.992 250.086 183.557 338.472 250.777 337.330
Employees - - 4 3 3 4 3 4 4 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 27.1%, from 347.090 euro in the year 2022, to 439.725 euro in 2023. The Net Profit increased by 87.313 euro, from 250.777 euro in 2022, to 337.330 in the last year.

Check the financial reports for the company - Oncoplastica Med Srl

Rating financiar

Financial Rating -
Oncoplastica Med Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Oncoplastica Med Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Oncoplastica Med Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Oncoplastica Med Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Oncoplastica Med Srl - CUI 35916710

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 0 42.094 30.809 19.280 9.974 2.124 2.196 5.759
Current Assets - - 90.624 180.213 141.655 237.712 307.079 435.411 258.342 337.370
Inventories - - 0 0 446 0 0 0 0 0
Receivables - - 0 0 2.757 73.695 4.168 1.121 1.500 1.635
Cash - - 90.624 180.213 138.452 164.017 302.911 434.290 256.842 335.735
Shareholders Funds - - 87.311 219.259 165.738 250.339 306.474 428.454 251.021 337.573
Social Capital - - 223 219 215 211 207 202 203 202
Debts - - 3.313 3.772 6.858 6.836 10.882 9.081 9.786 7.107
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 337.370 euro in 2023 which includes Inventories of 0 euro, Receivables of 1.635 euro and cash availability of 335.735 euro.
The company's Equity was valued at 337.573 euro, while total Liabilities amounted to 7.107 euro. Equity increased by 87.313 euro, from 251.021 euro in 2022, to 337.573 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Oncoplastica Med Srl

Comments - Oncoplastica Med Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.